Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study

AIM: To evaluate the safety profile of insulin detemir (IDet) in people with Type 2 diabetes mellitus (T2DM) in the Gulf countries in the 32-week, noninterventional LevSafe study. METHODS: People with T2DM whose physicians had opted to start IDet therapy were included in the study. Safety parameters...

Descripción completa

Detalles Bibliográficos
Autores principales: El Shiekh, Abdel Rahman, Farrag, Hesham A., Ashour, Tarek, Alshali, Khalid Zaki, AbdelFattah, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911832/
https://www.ncbi.nlm.nih.gov/pubmed/27366709
http://dx.doi.org/10.4103/2230-8210.183461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911832/
https://www.ncbi.nlm.nih.gov/pubmed/27366709
http://dx.doi.org/10.4103/2230-8210.183461

Ejemplares similares